ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be ...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 december 2022....
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
22 Nov 2022

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Fr...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
22 Nov 2022

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 december ...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
22 Nov 2022

Acarix beslutar om partiellt garanterad företrädesemission om cirka 52,9 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Acarix resolves on a partially guaranteed rights issue of approximately SEK 52.9 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, A...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
22 Nov 2022

Acarix resolves on a partially guaranteed rights issue of approximately SEK 52.9 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, A...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Acarix beslutar om partiellt garanterad företrädesemission om cirka 52,9 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
18 Nov 2022

Acarix presents at Redeye Life Science Day 2022

On November 24th at 14.50 CET Helen Ljungdahl Round, CEO of Acarix, will discuss the latest developments in the company in an in-depth ...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Nov 2022

Acarix presenterar på Redeye Life Science Day 2022

Den 24 november kl 14.50 kommer Helen Ljungdahl Round, VD för Acarix, att diskutera den senaste utvecklingen inom företaget i en ingåen...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Nov 2022

Acarix presents at Redeye Life Science Day 2022

On November 24th at 14.50 CET Helen Ljungdahl Round, CEO of Acarix, will discuss the latest developments in the company in an in-depth ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
18 Nov 2022

Acarix presenterar på Redeye Life Science Day 2022

Den 24 november kl 14.50 kommer Helen Ljungdahl Round, VD för Acarix, att diskutera den senaste utvecklingen inom företaget i...
Continue reading
  • «
  • ‹
  • 33
  • 34
  • 35
  • 36
  • 37
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.